by The growing prevalence of cardiovascular diseases such as hypertension has accelerated the demand for effective hypertension treatment medications such as nifedipine. Nifedipine helps lower blood pressure by relaxing the muscles in blood vessel walls thereby facilitating smooth blood flow. The global Nifedipine Medication Market is estimated to be valued at US$ 1260.52 Bn in 2024 and is expected to exhibit a CAGR of 9.4% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends driving the growth of the nifedipine medication market is the increasing adoption of nifedipine among hypertensive patients. This is attributed to its high effectiveness in controlling blood pressure along with fewer side effects as compared to other blood pressure lowering medications. As per data by the American Heart Association, over 103 million American adults suffer from hypertension. The high prevalence of hypertension has led to the rising sales of nifedipine medications globally. Furthermore, growing awareness about lifestyle-related diseases and their management is also augmenting the demand for nifedipine medication worldwide.
Segment Analysis
The global nifedipine medication market is fragmented, with hypertension as the dominant segment. Hypertension accounts for over 50% of the market share as nifedipine is one of the most commonly prescribed calcium channel blockers for the treatment of high blood pressure and related cardiovascular conditions. It works by relaxing blood vessels and improving blood flow, thereby lowering blood pressure both immediately and over time with continued use.
Key Takeaways
The Global Nifedipine Medication Market Demand is expected to witness high growth over the forecast period of 2024 to 2031.
Regional analysis shows North America is currently the largest and fastest growing regional market. The growth can be attributed to high awareness levels regarding hypertension management and strong presence of key pharmaceutical brands.
Key players operating in the nifedipine medication market are AB Volvo, Scania AB, Continental AG, Peloton Technology, and Daimler AG. The market is expected to experience healthy competition between these players during the forecast period.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
